Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Not Recruiting

Trial ID: NCT00482352

Age - 1 Year-30 Years Condition - Leukemia, Acute Lymphoid leukemia (ALL), Pediatric Cancer Gender - All Accepting Healthy Volunteers - No

Purpose

This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.

Official Title

Classification Of Acute Lymphoblastic Leukemia

Stanford Investigator(s)

Neyssa Marina

Eligibility


Inclusion Criteria:

   - Newly diagnosed acute lymphoblastic leukemia, defined by any of the following:

      - At least 25% blasts in the bone marrow

      - Absolute blast count at least 10,000/mm^3, if bone marrow aspiration is not
      performed

   - No prior registration on this study

View More
View Less

Intervention(s):

other: laboratory biomarker analysis

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Peds Hem/Onc CRAs
650-723-5535

New Trial Alerts

Receive email alerts when trials open to patients.

©2022 Stanford Medicine